Dexcom CFO Sylvain has 1,451 shares withheld for taxes
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Dexcom, Inc. (DXCM) reported that EVP, COO & CFO Jereme M. Sylvain had 1,451 common shares withheld on November 8, 2026, to cover tax withholding and remittance obligations connected with net settlement of restricted stock units; the footnote says this was not a sale. His direct holdings after the transaction were 145,377 shares, including 84,244 unvested restricted stock units.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock F1, F2 | 1,451 | $79.41 | $115K |
Footnotes (2)
- F1. Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of restricted stock units and does not represent a sale by the Reporting Person.
- F2. Included in this number are 84,244 unvested restricted stock units, 48,774 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 23,937 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 2,849 of which were granted on March 8, 2025 and shall vest through March 8, 2027, and 8,684 of which were granted on March 8, 2024 and shall vest through March 8, 2027.
Key Figures
Key Terms
net settlement financial
restricted stock units financial
tax withholding and remittance obligations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.